lawhern
Few in the chronic pain community carry as much gravitas as Dr. Red Lawhern, and even fewer have his reach and influence. His research and insights have been cited in hundreds of medical journals and policy reports.
His latest work can be found at – https://internationalpain.org/youarenotalone/
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
Comments 0